Innoviva Inc. (INVA)
INVA trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$20.74
-3.31% on the day
Market cap
$1.5B
Small cap
Revenue · 2025
$411.3M
+14.7% on 2024
Net income · 2025
Net income not in SEC XBRL data
0.0% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | INVA on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2004 |
| SEC CIK | 0001080014 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | DE |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $411.3M |
| Net income | Not in SEC XBRL data |
| Operating income | $163.7M |
| Net margin | 0.0% |
| Operating margin | 39.8% |
| Revenue growth | +14.7% |
| Cash | $550.9M |
| Total assets | $1.6B |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 3.6× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2013-01-18 |
| Latest annual report | 10-K/A | 2026-03-27 |
| Latest quarterly / interim | 10-Q | 2026-08-05 |
| Latest current report | 8-K | 2026-08-05 |
| Latest proxy | DEF 14A | 2026-03-24 |
Source: SEC EDGAR submissions feed, 1,002 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -0.3% |
| 1 month | +0.8% |
| 3 months | -5.4% |
| Year to date | +5.1% |
| 1 year | +24.0% |
| From 52-week high | -13.4% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| PAHC | Phibro Animal Health Corporation | $36.81 | -1.66% | $1.5B |
| QURE | uniQure N.V. | $21.28 | -2.56% | $1.5B |
| ETON | Eton Pharmaceuticals Inc. | $53.33 | -3.48% | $1.5B |
| RARE | Ultragenyx Pharmaceutical Inc. | $14.92 | -2.48% | $1.5B |
| CMPS | COMPASS Pathways Plc American Depository Shares | $11.14 | -3.38% | $1.5B |
| STOK | Stoke Therapeutics Inc. | $22.50 | -6.83% | $1.5B |
| PCRX | Pacira BioSciences Inc. | $36.31 | -0.11% | $1.4B |
| KRSA | Korsana Biosciences Inc. | $31.66 | -6.99% | $1.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier